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Loss of erythrocyte membrane deformability is one of the most crucial factors in developing complications associated 
with Type II diabetes. The observed loss of erythrocyte membrane deformability could be related to structural changes in the 
membrane. In this context, here, we have made an attempt at gaining a better insight (quantitative as well as qualitative) into 
the protein and lipid contents in erythrocyte membranes and their interrelationships in Type II diabetes. Age matched control 
(n=12) and Type II diabetic subjects (n=22) were selected for this study. Morphological characteristics were studied by 
atomic force microscopy (AFM). AFM study confirmed remarkable alterations in morphology of the diabetic erythrocytes. 
In diabetic erythrocytes following changes were noted: (i) Significant increase in membrane as well as cytosolic proteins 
with a marginal increase in phospholipids content; (ii) The membrane total lipids:protein, phospholipids:protein, 
cholesterol:protein and phospholipids:cholesterol (mole:mole) ratios decreased significantly; (iii). A reproducible decrease 
in docosahexaenoic acid (DHA) and Omega-3 index with increase in Omega-6:Omega-3 ratio in membrane fatty acids; and 
(iv) The SDS-PAGE analysis indicated that all membrane proteins increased in almost equal proportion leading to increased 
membrane protein content. The observed compositional and stochiometric changes in lipids, proteins and their ratios may 
underlie morphological alterations and loss of deformability. 
Keywords: Atomic force microscopy (AFM), Diabetic erythrocyte deformability, Erythrocyte membrane lipids/proteins 
Growing worldwide incidence of diabetes poses a 
serious challenge. According to 2019 survey of 
International Diabetes Federation, around 463 million 
adults of world population
1
 are currently living with 
Diabetes Mellitus (DM) and India is the second 
topmost country with the largest numbers of adults 
with diabetes i.e. 77 million
2
. The numbers is 
expected to increase significantly by 2030
3
. The 
primary physiological defect characterizing 
pathogenesis of Type II diabetes is hyperglycemia 
which is attributed to resistance to the biological 
action of insulin due to alterations in signalling 
downstream to the insulin receptor
4
. Eventually, Type 
II diabetes leads to the development of many serious 
complications such as nephropathy, retinopathy, 
cardiomyopathy, peripheral and cerebral neuropathy, 
starting with initiation of micro- and macro-
angiopathy
5
. More recently, it has been recognized 
that loss of deformability of erythrocytes is a 
characteristic feature of Type II diabetes
6,7
. 
Deformability is an essential and crucial attribute of 
the erythrocytes which enables them to squeeze 
through capillaries and regain their biconcave  
shape and size when they come out of capillaries 
which is essential to maintain the flexibility/ 
physiological function of the erythrocytes
8
. recent 
Scanning electron microscope (SEM) and a few 
Atomic force microscope (AFM) studies have 
demonstrated changes in structure, size and  
shape of Type II diabetes erythrocyte membranes in 
terms of surface deformation
9,10
. AFM is the widely 
used technique because of its higher resolution 
capacity in cytobiology to study the topographical 
structure of biological samples. AFM measures the 





The deformability of cell membrane is a composite 
function of two main components: the outer lipid 
bilayer leaflet composed of phospholipids and 
cholesterol with embedded proteins, and a spectrin-
based cytoskeleton which lies underneath the inner 
leaflet
11
. Any change in one of these components may 
alter the deformability and ultimately the flexibility of 
the cell membrane. There are reports which indicate 
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that loss of deformability could lead to fragmentations 
of the erythrocytes
12,13
; indeed, presence of 
erythrocyte fragments has been shown in kidney 
glomeruli of diabetic nephropathy patients
14
. It has 
been suggested that possibly the biochemical changes 
in lipid and protein composition can affect the physico-
chemical properties of the erythrocyte membrane. 




With this background in mind we tried to carry out 
qualitative and quantitative analysis of diabetic 
erythrocyte cell membrane components viz. proteins 
and lipids and their interrelationships. In the first 
place we characterized the Type II diabetic 
erythrocytes using AFM technique. In the next set of 
experiments we studied the quantitative aspects of 
proteins and lipids components of cell membrane and 
their interrelationships.  
 
Materials and Methods 
 
Sample selection 
For the present study, 12 age- and sex- matched 
healthy nondiabetic controls and 22 Type II diabetic 
subjects were included. The major criteria for 
inclusion in diabetic group were: glycated 
hemoglobin (HbA1c) >7.0% or fasting blood glucose 
(FBG) >126 mg/dL, BMI >22 kg/m
2
, and age  
40-60 years. The mean age was 47.62±1.19 and 
50.58±2.29 years respectively for control and diabetic 
groups. The values of FBG levels were 99.13±4.11 
and 236.86±13.10 mg/dL respectively for the two 
groups. The corresponding values of HbA1c were 
4.8±0.19 and 7.8±0.16 %. The plasma triglycerides 
levels for control and diabetic groups were 
respectively 146.13±10.69 and 182.75±11.5 mg/dL. 
The corresponding values for plasma cholesterol  
were 143.61±5.81 mg/dL and 174.13±6.58 mg/dL 
(Table 1). The Type II diabetic subjects continued 
their treatment with prescribed anti-diabetic agents.  
Fasting blood samples were collected after 
informed written consent. The study was conducted 
following Helsinki Convention Guidelines and was 
approved by Institutional Ethics Committee (Ethics 
Approval Number: DCGI Reg. No. ECR 518) of 
Bharati Vidyapeeth Deemed University Medical 
College, Pune, India. 
 
Collection of blood sample 
A volume of 5.0 mL fasting blood samples were 
collected by vein puncture in EDTA tubes, and 
aliquots were used for measurements of erythrocyte 
count, blood glucose level, total Hb, HbA1c and, 
plasma triglycerides and cholesterol. 
 
Atomic force microscopy (AFM) 
For AFM studies washed erythrocytes (details 
given below) were diluted 1:10 using 0.9% NaCl 
solution. A small portion of erythrocyte suspension 
was spread evenly on sterilized round silicone plate to 
form a monolayer. The sample was completely air 
dried for about 30 min
17,18
 and then subjected to AFM 
(Breuker, AFM multimode 8.0) measurements. A 
silicone probe with aluminium reflective coating on 
its backside (TEPSA, Bruker) was used for AFM 
imaging. The probe has a spring constant of 20-80 N/m, 
a tip curvature with a radius of 15 nm, and a 
resonance frequency of 70 KHz. The AFM probe and 
optical microscope were used to visualize the top 
view of anticipated cells. Eight to ten cells from 
different areas from each smear were randomly 
selected and scanned at the field (10×10 µm) to 
analyze the alteration in the morphology of cell 
membrane. Determination of AFM images and 
morphological parameters and surface roughness 
measurements were carried out using Bruker 
Nanoscope Analysis software 1.3.  
 
Isolation of membrane and cytosol protein from erythrocytes 
Erythrocytes were sedimented by centrifugation at 
400 g for 10 min and the plasma was carefully 
decanted and saved for further investigations. The 
buffy coat was discarded following gentle swirling 
with 0.9% NaCl solution. The packed cells were 
repeatedly washed and resuspended to original 
volume using 0.9% NaCl solution and the cell count 
Table 1 — Baseline characteristics of the subjects 
Parameter Control (n=12) Diabetic (n=22) 
Mean Age, (Years) 47.62±1.91 (range: 40 to 54) 50.58±2.29 (range: 41 to 60) 
Gender (Male/Female) 6/6 16/6 
Fasting blood sugar level (mg/dL) 99.13±4.11 (range: 84 to 115) 236.86±13.10 (range: 145 to 314) 
Erythrocyte Count (million/mm3 ) 4.9±0.23 (range: 4.16 to 5.7)  5.15±0.15 (range: 4.02 to 6.11)  
Hb (g /dL) 12.4±1 (range: 9.13 to 16.2) 13.1±0.6 (range: 9.3 to 17.6) 
HbA1c (%) 4.8±0.19 (range: 4.06 to 5.7) 7.8±0.16 (range: 7.06 to 9.7) 
Plasma Triglycerides (mg/dL) 146.13±10.69 (range: 108.5 to 186) 82.75±11.5 (range: 116.43 to 277.6) 
Plasma Cholesterol (mg/dL) 143.61±5.81 (range: 122.2 to 164.3) 174.13±6.58 (range: 135.7 to 233.3) 
[Results are given as mean ± SEM of number of observations indicated in parentheses] 




was recorded. The resuspended erythrocytes were 
lyzed (1:10) in 10 mM sodium phosphate buffer, pH 
7.4. Aliquots were used for estimation of total lysate 
proteins. The lysate was subjected to further 
centrifugation at 24700 g for 40 min to sediment 
membrane fraction and the supernatant was carefully 
separated for determination of total protein and 
hemoglobin contents. The membrane pellet was 
carefully resuspended in 14 mM Tris-HCl buffer pH 
7.4 and washed repeatedly using the same buffer and 
re-sedimented at 24700 g for 40 min. Finally, the 
pellet was suspended in 14 mM Tris-HCl buffer pH 
7.4 to a known volume. All operations were carried 
out at 0-4⁰C. 
Protein estimation was carried out by the method of 
Lowry et al.
19
. Estimation of hemoglobin was carried 
out by cyanmethemoglobin method
20
. For protein 
estimation the whole lysate and membrane proteins 
were solubilized using 10% SDS solution. The 
content of cytosolic protein was calculated by 
subtracting hemoglobin protein content from the 
protein content of membrane free supernatant.  
 
Extraction of Lipids 
Known aliquots of erythrocyte membrane 
suspension and plasma were used for extraction of 
lipids essentially according to the procedure of Folch 
et al.
21
. Aliquots were used for estimation of total 




Total lipid determination was carried out by 
phosphovanillin method
22
. Cholesterol estimation was 
according to method of Zlatkis et al.
23
. Aliquots of 
extracted lipids were digested with H2SO4 followed by 
digestion with 70% perchloric acid to liberate 
inorganic phosphate
24,25
. The phospholipids 
estimation was essentially according to the method of 
Katewa & Katyare
25
. Phospholipids content was also 
computed from the phosphovanillin values as 
described by Rouser et al.
26
. The values obtained by 
the two methods were in close agreement and were 
pooled for data presentation. 
 
Fatty acid analysis 
Fatty acid methyl esters (FAME) were prepared 
essentially according to the method of Ichihara et al.
27
; 
0.1 mL of internal standard (C17:0, 2 mg/mL in 
methanol) was included. The separation of FAME 
was carried out using 30 m fused silica capillary 
column with an internal diameter of 0.25 µm in an 
Agilent 7820A gas chromatography system with 
flame ionization detector (FID). Helium was used as 
carrier gas and nitrogen as a make-up gas. The split 
ratio was 25:1. The injection port and detector 
temperature was 250⁰C. The initial column 
temperature was 110⁰C and raised to 240⁰C with an 
increment of 3⁰C/min. The fatty acid peaks were 
identified based on retention time of the standard 
FAME mixture. The relative proportion of individual 
fatty acid (% area of total fatty acid) was quantified 
by integrating the area under peak and dividing the 
result by total area for all fatty acids. 
 
SDS-PAGE 
The erythrocyte membranes were solubilized in 
loading buffer containing 5% w/v SDS, 5% v/v  
2-mercaptoethanol, 10% v/v glycerol and 0.00125% 
w/v bromophenol blue in 0.0625 M Tris-HCl buffer, 
pH 6.8. SDS-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) was performed in 10% polyacrylamide 
gels according to the method of Laemmli
28
. The gel 
was stained using 0.5% w/v Coomassie Brilliant Blue 
R. The apparent molecular masses were calculated 
based on Rf values of the standard protein markers  
(Hi Media). After distaining, the gels were scanned in 
Bio-Rad Molecular Imager, ChemiDoc XRS + with 
Image Lab Software. The instrument gives gel image, 
gel scan, Rf values with molecular weights and 
percent distribution of the components. 
 
Statistical analysis 
Statistical analysis of the data was carried out by 
Student’s t-test using GraphPad Prism version 5. The 
results are given as mean ± SEM of the number of 
independent observations indicated. P values <0.05 




The baseline characteristics of the normal healthy 
controls and the diabetic group are given in Table 1 
which include value of mean age, gender, and levels 
of fasting blood sugar. It is also apparent that the 
erythrocyte count and the Hb levels were generally 
comparable in the two groups. However, as expected, 
the HbA1c levels were significantly high in the 
diabetic group. 
 
The representative AFM images of control and 
diabetic erythrocytes are shown in Fig. 1 (A & B), 
respectively which are in conformity with previously 
published reports
10,29
. Thus, in the control group, the 
erythrocytes show a typical concave shape with  
a diameter of 7.73 µm±0.15 µm and height of  
2.32 µm±0.12 µm (Fig. 1C), whereas the diabetic 




erythrocyte shows atypical shape with extended 
projections on membrane (Fig. 1D). Diabetic 
erythrocytes show decrease in size with a diameter of 
6.71 µm±0.05 µm and height of 1.35 µm±0.028 µm. 
Figure 1E shows that the concave depth of control 
erythrocyte is 263.13 nm±7.56 nm. By contrast, 
diabetic erythrocyte perceptibly shows a well-
developed balloon like convex shape (Fig. 1F). The 
surface roughness of erythrocyte membrane for 
control group is 2.37 nm ± 0.031 nm which decreases 





Fig. 1 — The AFM image of dry sample prepared from erythrocyte of (A) control subjects; and (B) diabetic patients; Image of a single 
erythrocyte of (C) control subjects; and (D) diabetic patients; and Geometrical profiles of (E) control erythrocyte; and (F) diabetic erythrocyte.  
 




The data in Table 3 show the protein content of 
whole erythrocytes, erythrocyte membrane and 
cytosol, and Hb from control and diabetic subjects. 
The values are given as µg per 10
6
 erythrocyte as well 
as mg per mL erythrocyte. It can be noted that the 
protein content of erythrocyte membranes and cytosol 
is more than doubled in the diabetic group, whereas 
the Hb content was comparable in both the groups. 
 
The data on protein and lipid content of erythrocyte 
membranes from control and diabetic subjects are 
given in Table 4. It is interesting to note that while the 
total lipid content was generally comparable in the 
two groups, the phospholipid content was 40% higher 
in the diabetic group. By contrast, the cholesterol 
content was somewhat lower although the observed 
decrease was not statistically significant.  
Based on these values given as µg/10
6
 erythrocyte 
(Table 4), we tried to compute the lipid:protein ratios 
as well as cholesterol:phospholipid ratios in 
erythrocyte membranes from the control and the 
diabetic subjects. These data are shown in Fig. 2. It is 
apparent that in the diabetic group the Total 
lipids:protein ratio decreased almost by 50 %. 
Similarly, phospholipid:protein ratio also decreased 
by 43%. Interestingly, the cholesterol:protein ratio 
decreased drastically by 62% in the diabetic group. 
this was also reflected in the mole: mole ratio of 
cholesterol:phospholipid. In the control group it was 
0.91 which is in close agreement with the values 
reported for human and rat erythrocytes
30,31
. However, 
in the diabetic group there was a 32% reduction in the 
ratio. Identical results were obtained when the data 
were presented on the basis of µg content per mL of 
erythrocyte (Fig. not shown). 
 
In view of the observed changes in the 
phospholipids and cholesterol contents, it was of 
interest to find out if diabetic state also affected the 
membrane fatty acid composition. These results are 
given in Table 5 which shows that in the diabetic state 
the proportion of docosahexaenoic acid (DHA) 
decreased resulting in lowering of the omega-3 index. 
Consequently, the Omega-6/Omega-3 ratio increased. 
Almost parallel changes were noted for plasma fatty 
acid composition except that the proportion of 
palmitic acid increased marginally which was 
statistically significant (Table 5). 
 
Table 2 — Morphological measurements of control and diabetic 
erythrocytes 
 Control (n=12) Diabetic (n=22) 
Diameter 7.73 µm±0.15 µm 6.71 µm±0.05 µma 
Height  2.32 µm±0.12 µm 1.35 µm±0.028 µma 
Concave Depth 263.13 nm±7.56 nm convex 
Surface Roughness 2.37 nm±0.031 nm 1.71 nm±0.027 nma 
[Results are given as mean±SEM of number of observations 
indicated in parentheses, aP <0.0001] 
. 
Fig. 2 — Relative proportions of lipids and proteins in erythrocyte 
membranes from control and diabetic subjects. [(A) Total lipids; 
and (B) Cholesterol. *P <0.05; **P <0.0001] 
Table 3 — Recovery of erythrocyte cytosolic and membrane proteins from control and diabetic subjects 
Parameter/Fraction µg/106 erythrocyte mg/mL of erythrocytes 
 Control (n=12) Diabetic (n=22) Control (n=12) Diabetic (n=22) 
Whole erythrocyte 38.40±2.40 41.40±3.40NS 189.50±9.50 214.0±11.0NS 
Erythrocyte membrane 0.61±0.09 1.41±0.05b 2.79±0.32 6.88±0.56b 
Cytosol with Hb 29.42±1.01 30.25±1.62 138.68±7.18 144.3±7.77 
Hb 28.01±1.00 27.175±1.48 132.08±7.24 130.4±7.65 
Cytosol 1.41±0.13 3.076±0.31a 6.61±0.42a 13.89±0.75 
[Results are given as mean±SEM of number of observations indicated in parentheses, aP <0.02, bP <0.0001; NSnot significant] 
 
Table 4 — Protein and lipid content in erythrocyte membranes from control and diabetic subjects 
Parameter  µg/106 erythrocyte mg/mL of erythrocyte 
 Control (n=12) Diabetic (n=22) Control (n=12) Diabetic (n=22) 
Protein 0.61±0.09 1.41±0.05b 2.79±0.32 6.88±0.56b 
Total Lipids 0.65±0.06 0.79±0.05 NS 3.03±0.21 3.79±0.32 NS 
Phospholipids 0.45±0.05 0.61±0.05a 2.08±0.14 2.95±0.30a 
Cholesterol  0.20±0.02 0.18±0.01 NS 0.95±0.10 0.85±0.06 NS 
[Results are given as mean±SEM of number of observations indicated in parentheses, aP <0.05, bP <0.0001; NSnot significant] 




In the next set of experiment, we examined the 
SDS polyacrylamide gel profiles of the erythrocyte 
membrane proteins since the membrane proteins had 
more than doubled in the diabetic group (Table 3). In 
particular, we wanted to find out if there was uniform 
or disproportionate increase in the membrane protein 
components. The typical SDS-PAGE profiles of 
erythrocyte membrane proteins and the corresponding 
densitometric traces from the control and the diabetic 
subjects are shown in Fig. 3. As is clear, the patterns 
were comparable for the two groups. Also, the percent 
distribution of the components was practically 
unaltered. Thus the percent distribution values for 
bands 1-7 in the control group were 22.0, 36.4, 18.1, 
9.5, 7.0, 2.7 and 2.5; the respective values for the 
diabetic group were 26.7, 36.9, 18.5, 9.5, 3.6, 2.1 and 
2.6. In other words, in the diabetic group where the 
total membrane proteins had increased significantly 




The results of the present studies have shown that 
while the content of total Hb was comparable in 
control and diabetic subjects, there was a significant 
increase in the erythrocyte membrane as well as 
cytosolic proteins in the diabetic group. SDS-PAGE 
analysis indicated that there was a uniformly 
Table 5 — Fatty acid composition of erythrocyte membrane and plasma 
Fatty acid Erythrocyte membrane Plasma 
 Control (n=12) Diabetic (n=22) Control (n=12) Diabetic (n=22) 
Palmitic acid (C16:0) 25.96±1.52 24.55±0.95NS 23.30±0.65 25.45±0.52b 
Palmitoleic acid (C16:1) 1.75 ±0.37 1.73±0.48NS 1.19±0.20 1.8±0.44NS 
Stearic acid (C18:0) 17.28 ±0.63 16.85±0.90NS 9.33±0.66 9.70±0.77NS 
Oleic acid (C18:1) 17.2±0.99 21.06±1.66NS 21.53±1.02 21.03±0.69NS 
Linoleic acid (C18:2n6) 14.53±1.02 18.84±1.56NS 33.39±1.05 33.18±1.45NS 
Alpha linolenic acid (C18:3n3) 2.24±0.42 2.71±0.49NS 1.50±0.18 1.22±0.16NS 
Arachidonic acid (C20:4n6) 12.22±0.81 10.72±0.61NS 6.80±0.37 6.92±0.48NS 
Eicosapentaenoic acid (C20:5n3) 0.91±0.24 0.53±0.19NS 0.65±0.48 0.22±0.04NS 
Docosahexaenoic acid (C22:6n3) 3.62±0.94 0.90±0.25e 1.39±0.52 0.43±0.09b 
SFA 43.24±1.9 41.39±1.60NS 32.62±1.08 35.15±0.94NS 
MUFA 18.91±1.42 22.79±1.49NS 22.73±1.14 22.83±0.60NS 
PUFA 34.61±1.7 33.70±1.41NS 43.74±1.40 41.96±1.11NS 
O-6 PUFA 27.35±1.32 29.62±1.41NS 40.19±1.10 40.10±1.18NS 
O-9 MUFA 17.20±0.99 21.06±1.66NS 21.53±1.02 21.03±0.69NS 
O-3 PUFA 7.25±1.16 4.22±0.75a 3.54±0.92 1.87±0.20a 
O-3 Index (ALA+EPA+DHA) 5.01±1.16 1.51±0.44d 2.04±0.97 0.65±0.11NS 
O-6: O-3 ratio 4.57±1.04 9.61±1.06c 17.47±1.51 30.88±4.18a 
[SFA, Saturated fatty acids; MUFA, Monounsaturated fatty acids; PUFA, Polyunsaturated acid; O-6 PUFA, Ꞷ-6 Polyunsaturated acid; O-9 
MUFA, Ꞷ-9 Monounsaturated acid; O-3 PUFA, Ꞷ-3 Polyunsaturated acid; O-3 index, Ꞷ-3 index; O-6:O-3 ratio, Ꞷ-6 : Ꞷ-3 ratio. ALA, 
Alpha linolenic acid; EPA, Eicosapentaenoic acid; DHA, Docosahexaenoic acid. Results are given as mean±SEM of number of observations 




Fig. 3 — (A) SDS−PAGE pattern; and (B) densitometric scan profile of the erythrocyte membrane proteins. [STD, Standard protein 
marker with respective molecular weight; C, representative sample from control subject; and D, diabetic patient; and Hb, Hemoglobin] 
 




proportionate increase in all the membrane protein 
components in Type II diabetes. Additionally, it was 
also noted that there was only a marginal increase in 
the phospholipids content and a small but 
insignificant decrease in cholesterol content of the 
diabetic erythrocyte membrane. Consequently, the 
membrane total lipid:protein, phospholipids:protein, 
cholesterol:protein and cholesterol:phospholipids 
(mole:mole) ratios decreased drastically and 
significantly (Fig. 2). The total lipid:protein ratio and 
phospholipids: cholesterol (mole:mole) ratio of 
around 1.0 has been reported by other researchers 
including our research group following pioneering 
work of Davson & Danielli
11,31,32
. Thus, in the 
diabetic state, the erythrocyte membrane did not 
display normal stochiometric structural attributes. In 
other words, abnormalities in membrane structural 
composition were apparent. This was also reflected in 
AFM analysis (Fig. 1). The lipids constitute major 
structural components for stability and functional 
attributes of the membrane. Proper stoichiometry of 
lipids and protein in membrane is essential for 
membrane structure-function relationship. In view of 
this, it is more likely than not, that the observed 
drastic alterations in membrane composition and 
make-up as cited above could possibly be the 
underlying factors causing instability of the 
membrane. In other words these stochiometric 
changes could ultimately lead to the loss of 
deformability leading to the development of 
pathogenesis of diabetic complications ensuing from 
micro- and macro- angiopathies. Additionally, almost 
two fold increase in membrane proteins deserves 
some comment. It has been reported that spectrin-
ATP interaction plays an important role in regaining 
the normal shape of erythrocyte
33,34
. In this 
connection, it may be manifested that the energy 
potential of diabetic erythrocytes is comparable to the 
normal erythrocytes. Thus, Kono et al.
35
 has reported 
the ATP content of normal and diabetic erythrocyte is 
comparable. This would mean that there is an 
inadequate spectrin-ATP interaction in diabetic 
erythrocyte and therefore the diabetic erythrocyte may 
not be able to regain their shape. This inturn can lead 
to loss of deformability. In all probability, it is likely 
that the micro- and macro- angiopathies occur as a 
result of blockage of circulation in the capillaries due 
to accumulation of fragments of circulating 
erythrocytes. As has been pointed out above in the 
introduction section, presence of erythrocyte 
fragments have been shown in kidney glomeruli of 
diabetic nephropathy patients
14
. As far as we are 
aware, the disproportionate membrane protein and 
lipid stoichiometries, reported here in Type II 
diabetes, have not been reported thus far. The 
mechanism and significance of these changes need to 
be studied.  
The fatty acid analysis revealed that there was 
reproducible decrease in DHA and omega-3 index and 
increased omega-6/omega-3 ratio. Parallel and similar 
changes were noted even for fatty acid composition of 
diabetic plasma except that the proportion of palmitic 
acid was elevated (Table 5). It has been reported that 
in diabetic state the levels of fatty acid elongase and 
desaturase decrease significantly
36
. It is possible that 
this condition may affect the fatty acid profile of 
erythrocyte membrane or plasma to some extent. The 
SDS-PAGE analysis revealed that all membrane 
proteins increased in almost equal proportion leading 
to increased membrane protein. 
Increased non-enzymatic glycosylation leading to 
formation of advanced glycated end products (AGEs) 
is well documented
37
. This could be another factor 
responsible for loss of deformability. Increased 
incorporation of 
3
H in diabetic membrane proteins has 
already been demonstrated. In the present studies we 
could not pursue this point for lack of sufficient 
membrane material. 
Erythrocytes are derived in the red bone marrow 
from pluripotent stem cells that give rise to all types 
of blood cells. Nucleated erythroblasts are committed 
to becoming mature erythrocytes
38
. It is well 
recognized that in type II diabetes, altered/defective 
insulin receptors are present in insulin responsive 
tissues
39
. These changes ultimately lead to improper 
utilization and metabolism of glucose. Besides, the 
cellular and tissue physiological and biochemical 
functions are drastically affected. Although it is not 
clear at this stage if bone marrow cells have also 
possess insulin receptor. If so, it is likely that in the 
diabetic state the insulin receptor even in the bone 
marrow cells may be altered which could lead to 
cellular dysfunction and erroneous signaling. One 
therefore wonders, whether such a condition would 
lead to defective membrane formation and altered 
make-up of membrane in terms of lipid: protein 
composition. Such an assumption is also supported by 
the fact that even the content of cytosolic proteins 
increased. The hyperactivation of gene(s) for 
synthesis of membrane and cellular protein 




components could also result in change in turgor 
pressure. Taken together, the results would suggest 
that the defective membrane make-up could be the 
underlying cause for loss of membrane deformability 
leading to fragmentation
10
 which is ultimate cause for 
beginning of microangiopathy. 
In view of the above, it may be suggested that 
efforts should be directed towards restoring normal 
process of erythropoiesis which will eliminate, to a 




The present study has shown that in erythrocytes 
from Type II diabetic subjects there was almost two 
fold increase in the membrane protein content. 
However, there was only marginal increase in total 
lipids and phospholipid contents implying 
disproportionate stoichiometric changes in lipid: 
protein interactions. This is suggestive of alterations 
in structural features of the membrane. Additionally 
the result suggests that due to increased in membrane 
protein content, inadequate interaction between 
spectrin and ATP could lead to loss of deformability 
in diabetic erythrocytes. 
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